BOA Session
Chair: Amar Rangan
Agenda
Safe integration of changing technologies in Orthopaedics
10:30 – 10:45: David Lawson, Director of Medical Technology & Innovation, Department of Health and Social Care (DHSC)
Navigating a Diffused Health System
10:45 – 11:00: Josh Burke, NIHR Clinical Lecturer & Co-founder, RCSEng Innovation Hub
The Learning Curve: Technology-Enhanced Surgical Training
Guiding evidence-based adoption
11:00 – 11:15: Amar Rangan, Chair, Royal College of Surgeons Clinical Trials Initiative, University of York & Vice President, BOA
Clinical Trials: Guiding Evidence-Based Adoption
11:15 – 11:30: Luke Farrow, SCREDS Clinical Lecturer, University of Aberdeen
Big Data & AI: Guiding Evidence-Based Adoption
Ensuring and Enhancing Patient Safety
11:30 – 11:45: Stella Vig, National Medical Director for Secondary Care & Quality, NHS England
Ensuring and Enhancing Patient Safety: The Role of Mentorship, Team Training, Structured Training and Credentialing, Innovation, and Governance
11:45 – 12:00: Q&A (Led by Alex Liddle, Surgical Specialty Lead, BOA Research Committee)
Prof Amar Rangan holds the Mary Kinross Trust and Royal College of Surgeons Chair at Hull York Medical School (HYMS) and Department of Health Sciences, University of York.
He is a specialist shoulder and elbow surgeon at South Tees Hospitals NHS Foundation Trust in Middlesbrough, providing district and tertiary services in his specialty.
He also holds a full professorship with the faculty of medical sciences and NDORMS, University of Oxford.
Amar has held key national leadership roles: President of the British Elbow and Shoulder Society, trustee of the British Orthopaedic Association, and surgeon member of the National Joint Registry Steering Committee.
Amar is a designated supervisor for HYMS integrated academic training and supervises pre-doctoral and doctoral studentships.
He is fellowship director for the nationally accredited shoulder and elbow fellowship at South Tees Hospitals and is course director for the postgraduate MCh(Orth) programme in Teesside.
Amar leads a programme of clinical and translational research, including NIHR funded multi-centre clinical trials.
He has published widely in trauma and orthopaedics, particularly in shoulder and elbow surgery, where his work has influenced clinical practice, national guidelines, and policy.
He is chair of MedConnectNorth and is a member of the NIHR i4i Challenge Awards Committee.
Alex is a consultant hip and knee surgeon at Imperial College Healthcare NHS Trust and Clinical Associate Professor at Imperial College. His clinical practice revolves around partial, total and revision knee replacement, hip resurfacing, primary and revision hip replacement. His research focusses on improving outcomes and preventing complications of joint replacement, including work on optimising fixation in cementless implants, interventions to prevent and treat prosthetic joint infection, and use of routinely collected data to improve patient selection and surgical practice. He is Surgical Speciality Lead for elective orthopaedics at the Royal College of Surgeons of England, sits on the research committee of the British Orthopaedic Association, and is Chief Medical Officer of Osstec, an Imperial spinout company developing implants based on novel cementless lattice technologies.
